Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancerFormisano, Luigi ; Lu, Yao ; Servetto, Alberto ; Hanker, Ariella B ; Jansen, Valerie M ; Bauer, Joshua A ; Sudhan, Dhivya R ; Guerrero-Zotano, Angel L ; Croessmann, Sarah ; Guo, Yan ; Ericsson, Paula Gonzalez ; Lee, Kyung-Min ; Nixon, Mellissa J ; Schwarz, Luis J ; Sanders, Melinda E ; Dugger, Teresa C ; Cruz, Marcelo Rocha ; Behdad, Amir ; Cristofanilli, Massimo ; Bardia, Aditya ; O'Shaughnessy, Joyce ; Nagy, Rebecca J ; Lanman, Richard B ; Solovieff, Nadia ; He, Wei ; Miller, Michelle ; Su, Fei ; Shyr, Yu ; Mayer, Ingrid A ; Balko, Justin M ; Arteaga, Carlos LNature communications, 2019-03, Vol.10 (1), p.1373-1373, Article 1373 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
|
2 |
Material Type: Artigo
|
Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast CancerJansen, Valerie M ; Bhola, Neil E ; Bauer, Joshua A ; Formisano, Luigi ; Lee, Kyung-Min ; Hutchinson, Katherine E ; Witkiewicz, Agnieszka K ; Moore, Preston D ; Estrada, Mónica Valéria ; Sánchez, Violeta ; Ericsson, Paula G ; Sanders, Melinda E ; Pohlmann, Paula R ; Pishvaian, Michael J ; Riddle, David A ; Dugger, Teresa C ; Wei, Wenyi ; Knudsen, Erik S ; Arteaga, Carlos LCancer research (Chicago, Ill.), 2017-05, Vol.77 (9), p.2488-2499 [Periódico revisado por pares]United States: American Association for Cancer Research, IncTexto completo disponível |
|
3 |
Material Type: Artigo
|
Current Landscape of Targeted Therapies for Hormone-Receptor Positive, HER2 Negative Metastatic Breast CancerBallinger, Tarah J ; Meier, Jason B ; Jansen, Valerie MFrontiers in oncology, 2018-08, Vol.8, p.308-308 [Periódico revisado por pares]Switzerland: Frontiers Media S.ATexto completo disponível |
|
4 |
Material Type: Artigo
|
Proline rich 11 (PRR11) overexpression amplifies PI3K signaling and promotes antiestrogen resistance in breast cancerLee, Kyung-Min ; Guerrero-Zotano, Angel L ; Servetto, Alberto ; Sudhan, Dhivya R ; Lin, Chang-Ching ; Formisano, Luigi ; Jansen, Valerie M ; González-Ericsson, Paula ; Sanders, Melinda E ; Stricker, Thomas P ; Raj, Ganesh ; Dean, Kevin M ; Fiolka, Reto ; Cantley, Lewis C ; Hanker, Ariella B ; Arteaga, Carlos LNature communications, 2020-10, Vol.11 (1), p.5488-15, Article 5488 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
|
5 |
Material Type: Artigo
|
From Biology to Therapy: Improvements of Therapeutic Options in Lung CancerFormisano, Luigi ; Jansen, Valerie M ; Marciano, Roberta ; Bianco, RobertoAnti-cancer agents in medicinal chemistry, 2018-01, Vol.18 (9), p.1235-1240 [Periódico revisado por pares]Netherlands: Bentham Science Publishers LtdTexto completo disponível |
|
6 |
Material Type: Artigo
|
Thermal proteome profiling of breast cancer cells reveals proteasomal activation by CDK4/6 inhibitor palbociclibMiettinen, Teemu P ; Peltier, Julien ; Härtlova, Anetta ; Gierliński, Marek ; Jansen, Valerie M ; Trost, Matthias ; Björklund, MikaelThe EMBO journal, 2018-05, Vol.37 (10), p.n/a [Periódico revisado por pares]England: Blackwell Publishing LtdTexto completo disponível |
|
7 |
Material Type: Artigo
|
Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR + /HER2 - Breast CancerHurvitz, Sara A ; Martin, Miguel ; Press, Michael F ; Chan, David ; Fernandez-Abad, María ; Petru, Edgar ; Rostorfer, Regan ; Guarneri, Valentina ; Huang, Chiun-Sheng ; Barriga, Susana ; Wijayawardana, Sameera ; Brahmachary, Manisha ; Ebert, Philip J ; Hossain, Anwar ; Liu, Jiangang ; Abel, Adam ; Aggarwal, Amit ; Jansen, Valerie M ; Slamon, Dennis JClinical cancer research, 2020-02, Vol.26 (3), p.566-580 [Periódico revisado por pares]United StatesTexto completo disponível |
|
8 |
Material Type: Artigo
|
Clinical Significance of PIK3CA and ESR1 Mutations in Circulating Tumor DNA: Analysis from the MONARCH 2 Study of Abemaciclib plus FulvestrantTolaney, Sara M ; Toi, Masakazu ; Neven, Patrick ; Sohn, Joohyuk ; Grischke, Eva-Maria ; Llombart-Cussac, Antonio ; Soliman, Hatem ; Wang, Hong ; Wijayawardana, Sameera ; Jansen, Valerie M ; Litchfield, Lacey M ; Sledge, George WClinical cancer research, 2022-04, Vol.28 (8), p.1500-1506 [Periódico revisado por pares]United StatesTexto completo disponível |
|
9 |
Material Type: Artigo
|
Treatment of Triple-Negative Breast Cancer with TORC1/2 Inhibitors Sustains a Drug-Resistant and Notch-Dependent Cancer Stem Cell PopulationBhola, Neil E ; Jansen, Valerie M ; Koch, James P ; Li, Hua ; Formisano, Luigi ; Williams, Janice A ; Grandis, Jennifer R ; Arteaga, Carlos LCancer research (Chicago, Ill.), 2016-01, Vol.76 (2), p.440-452 [Periódico revisado por pares]United StatesTexto completo disponível |
|
10 |
Material Type: Artigo
|
Is There a Future for AKT Inhibitors in the Treatment of Cancer?Jansen, Valerie M ; Mayer, Ingrid A ; Arteaga, Carlos LClinical cancer research, 2016-06, Vol.22 (11), p.2599-2601 [Periódico revisado por pares]United StatesTexto completo disponível |